OrphoMed, Inc.
www.orphomed.comOrphoMed is a clinical-stage company with a proprietary dimer therapeutics platform. Our current focus is on developing therapies for irritable bowel syndrome with diarrhea (IBS-D), acute and chronic pain, and cystic fibrosis.
Read more
OrphoMed is a clinical-stage company with a proprietary dimer therapeutics platform. Our current focus is on developing therapies for irritable bowel syndrome with diarrhea (IBS-D), acute and chronic pain, and cystic fibrosis.
Read more
Country
State
California
City (Headquarters)
San Francisco
Industry
Employees
1-10
Founded
2014
Estimated Revenue
$1 to $1,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Co Founder
Email ****** @****.comPhone (***) ****-****
Technologies
(8)
Reach decision makers at OrphoMed, Inc.
Free credits every month!
OrphoMed, Inc. FAQ
San Francisco, United States
Pharmaceutical Manufacturing
We'll help you understand if Lusha can solve your business needs.
